PECAM1 and chronic obstructive pulmonary disease: Our results show a decrease in the circulating cell CD31 mRNA, CD34 mRNA and miR-126-3p expression in patients with moderate COPD, and might reflect a state of relative disease stability whereas higher numbers in patients with severe COPD may be attributable to more severe systemic inflammation and the frequency of exacerbations and complications such as cardiovascular diseases.